Cardiovascular morbidity and mortality in patients treated with hemodialysis - Epidemiological analysis

Vojnosanitetski Pregled

Volumn 65, Issue 12, 2008, Pages 893-900

  Petrović, Dejan ^a,c   Stojimirović, Biljana ^b  

^a Clinical Center   (Macedonia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Clinic for Urology and Nephrology   (Serbia)

Author keywords

Cardiovascular diseases; Homocysteine; Hypertrophy, left ventricular; Morbidity; Mortality; Prevalence; Renal dialysis; Risk factors

Indexed keywords

ALBUMIN; HOMOCYSTEINE; TROPONIN I; TROPONIN T;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BIOCHEMISTRY; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; CROSS-SECTIONAL STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORPHOLOGY; MORTALITY; PERICARDIAL EFFUSION; PREVALENCE; PROTEIN BLOOD LEVEL; VALVULAR HEART DISEASE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RISK FACTOR;

CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS;

EID: 59749092458     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP0812893P     Document Type: Article

References (48)

1. Parfrey PS. Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant 2000; 15 Suppl 5: 58-68. (Pubitemid 30784394)
2. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003; 63: S105-10. (Pubitemid 36605875)
3. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006; 70(1): 26-33. (Pubitemid 44000117)
4. Herzog CA. Can we prevent sudden cardiac death in dialysis patients? Clin J Am Soc Nephrol 2007; 2(3): 410-412
5. Parfrey PS, Collingwood P, Foley RN, Bährle A. Images in nephrology. Left ventricular disorders detected by M-mode echocardiography in chronic uraemia. Nephrol Dial Transplant 1996; 11(7): 1328-1331
6. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001; 12(5): 1079-1084 (Pubitemid 32378350)
7. Ie EH, Zietse R. Evaluation of cardiac function in the dialysis patient - a primer for the non-expert. Nephrol Dial Transplant 2006; 21(6): 1474-1481 (Pubitemid 44063119)
8. Murphy SW. Management of heart failure and coronary artery disease in patients with chronic kidney disease. Semin Dial 2003; 16(2): 165-172 (Pubitemid 37356829)
9. Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant 2004; 19(6): 1360-1362 (Pubitemid 38786723)
10. Doulton T, Sabharwal N, Cairns HS, Schelenz S, Eykyn S, O'Donnell P, et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int 2003; 64(2): 720-727 (Pubitemid 36871947)
11. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60(1): 350-357 (Pubitemid 32587574)
12. Ostermann M. Cardiac arrests in hemodialysis patients: An ongoing challenge. Kidney Int 2008; 73(8): 907-908
13. Rigatto C, Parfrey PS. Ureamic Cardiomyopathy: an Overload Cardiomyopathy. J Clin Basic Cardiol 2001; 4(2): 93-95
14. Zoccali C, Mallamaci F, Tripepi G. Novel Cardiovascular Risk Factors in End-Stage Renal Disease. J Am Soc Nephrol 2004; 15(Suppl 1): 77-80. (Pubitemid 38018461)
15. Petrović D, Stojimirović B. Homocystein as risk factor for cardiovascular complications in hemodialysis patients. In: Radenković S, editor. Cardionephrology 2. Naiss: GIP "PUNTA", 2005; p. 31-36 (Serbian)
16. Petrović D, Stojimirović B. Managing dyslipidemia in dialysis patients. In: Stefanović V, editor. Nephrology based on proofs. Medical faculty Naiss: "GRAFOLIK", 2006. p. 69-79. (Serbian)
17. Petrović D, Stojimirović B. Vascular access blood flow for hemodialysis - a risk factor for developoment of cardiovascular complications in hemodialysis patients. Med Rev 2007; 60(3-4): 183-186 (Serbian)
18. Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 2005; 16(6): 1803-1810 (Pubitemid 41716487)
19. Agarwal R. Hypertension and survival in chronic hemodialysis patients - past lessons and future opportunities. Kidney Int 2005; 67(1): 1-13. (Pubitemid 40019221)
20. Agarwal R. Management of hypertension in hemodialysis patients. Hemodial Int 2006; 10(3): 241-248 (Pubitemid 43923206)
21. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002 ; 61(2): 609-614 (Pubitemid 34102603)
22. Liu J, Rosner MH. Lipid abnormalities associated with endstage renal disease. Semin Dial 2006; 19(1): 32-40.
23. Petrović D, Stojimirović B. Prevalence of risk factors for development cardiovascular complication in hemodialysis patients. In: Cardionephrology 3. Radenvković S. ed. GIP "PUNTA", Naiss, 2007. p. 35-43. (Serbian)
24. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, et al. Left ventricular mass monitoring in the follow up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004; 65(4): 1492-1498 (Pubitemid 38406992)
25. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10(7): 1606-1615 (Pubitemid 29297538)
26. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16(2): 111-117 (Pubitemid 37356823)
27. Balović G, Petrović D. Echocardiographic assessment of left ventricular hypertrophy in patients with end-stage renal failure. Medicus 2006; 7(3): 112-115 (Pubitemid 44955031)
28. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5(12): 2024-2031
29. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11(7): 1277-1285 (Pubitemid 26241416)
30. Seibert E, Kuhlmann MK, Levin NW. Modifiable risk factors for cardiovascular disease in CKD patients. Contrib Nephrol 2005; 149: 219-229 (Pubitemid 43265019)
31. Ventura JE, Tavella N, Romero C, Petraglia A, Báez A, Muñoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 2002 ; 17(10): 1795-1801 (Pubitemid 35174292)
32. London GM, Pannier B, Marchais SJ, Guerin AP. Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 2000; 11(4): 778-783 (Pubitemid 30171888)
33. Ribeiro S, Ramos A, Brandao A, Guerra A, Resina C, Vila-Lobos A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13(8): 2037-2040 (Pubitemid 28356772)
34. Rufino M, Garcia S, Jimenez A, alvarez A, Miquel r, Delgado P, et al. Heart valve calcification and calcium x phosphorus product in hemodialysis patients: analysis of optimum values for its prevention. Kidney Int 2003; 63(Suppl 85): 115-118
35. Gussak I, Gussak HM. Sudden cardiac death in nephrology: focus on acquired long QT syndrome. Nephrol Dial Transplant 2007; 22(1): 12-14 (Pubitemid 46050317)
36. Zebe H. Atrial fibrillation in dialysis patients. Nephrol Dial Transplant 2000; 15(6): 765-768 (Pubitemid 30311991)
37. Wood JE, Mahnensmith RL. Pericarditis associated with renal failure: evolution and management. Semin Dial 2001; 14(1): 61-66 (Pubitemid 33720830)
38. Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol 2000; 54(3): 234-239 (Pubitemid 30690562)
39. Meier P, Vogt P, Blanc E. Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron 2001; 87(3): 199-214. (Pubitemid 32268561)
40. Herzog CA. Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome. Kidney Int 2003; 63(Suppl 84): 197-200. (Pubitemid 36513408)
41. Herzog CA. Cardiac arrest in dialysis patients: taking a small step. Semin Dial 2004; 17(3): 184-185 (Pubitemid 38824498)
42. Wu VC, Lin LY, Wu KD. QT interval dispersion in dialysis patients. Nephrology (Carlton) 2005; 10(2): 109-112 (Pubitemid 40776267)
43. Nakamura S, Ogata C, Aihara N, Sasaki O, Yoshihara F, Nakahama H, et al. QTc dispersion in haemodialysis patients with cardiac complications. Nephrology (Carlton) 2005; 10(2): 113-118 (Pubitemid 40776268)
44. Herzog CA. How to manage the renal patient with coronary heart disease: the agony and theecstasy of opinion-based medicine. J Am Soc Nephrol 2003; 14(10): 2556-2572 (Pubitemid 37169341)
45. Zoccali C, Tripepi G, Mallamaci F. Predictors of cardiovascular death in ESRD. Semin Nephrol 2005; 25(6): 358-362 (Pubitemid 41655967)
46. Nolan CR. Strategies for Improving Long-Term survival in Patients with ESRD. J Am Soc Nephrol 2005; 16(11 Suppl 2): 120-127 (Pubitemid 46173249)
47. McCullough PA. Coronary artery disease. Clin J Am Soc Nephrol 2007; 2(3): 611-616
48. Johnson DW, Craven AM, Isbel NM. Modification of cardiovascular risk in hemodialysis patients: an evidence-based. Hemodial Int 2007; 11(1): 1-14. (Pubitemid 46128673)